跳至主要内容
临床试验/DRKS00024176
DRKS00024176尚未招募不适用

The corona pandemic (COVID-19) as a prognostic factor - Is there COVID upstaging in patients with head and neck tumors? - CoV-UP

niversitätsklinikum Leipzig0 个研究点目标入组 100 人开始时间: 2021年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • The study population includes all adult patients who presented to the Department of Oral and Maxillofacial Surgery at the University of Leipzig in 2019-2020, including the second pandemic wave (early 2021), due to a new tumor disease or a tumor recurrence. The inclusion criterion is presentation to the head and neck tumor board, the skull base board, or the skin tumor board of Leipzig University Hospital. Thus, patients with malignancies of the oral cavity and pharynx, but also patients with malignancies of the skin were systematically included.

排除标准

  • Age less than 18 years, Benign tumors, Basal cell carcinomas, Malignant melanomas, Metastases to head and neck of other tumors, CUP, Isolated lymph node metastases of known tumors.

研究者

发起方
niversitätsklinikum Leipzig

相似试验